How Second-Line Chemotherapy Is Shaping Colon Cancer Treatment
Second-line chemotherapy emerges as a pivotal strategy in the treatment of metastatic colon cancer, providing essential alternatives for patients unresponsive to initial treatments. Key agents like bevacizumab, when combined with irinotecan-based regimens, offer significant survival benefits despite potential toxicities. Advances in targeted therapies further enhance treatment efficacy, while personalized approaches consider patient-specific factors such as […]
3 minute read